IBM WATSON HEALTH and Quest Diagnostics announced the launch of IBM Watson Genomics from Quest Diagnostics, a service that combines cognitive computing with genomic tumor sequencing. Memorial Sloan Kettering Cancer Center will supplement Watson’s corpus of scientific data with OncoKB, a precision oncology knowledge base to help inform precision treatment options for cancer patients. Watson’s...
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
